Evaluation of quality and safety parameters of DEET commercial repellents: photostability, penetration/permeation and eye irritation studies
Evaluation of quality and safety parameters of DEET commercial repellents
DOI:
https://doi.org/10.22456/2527-2616.124882Keywords:
Penetration/permeation, HET-CAM, degradation kinetics, repellents, DEETAbstract
N',N'-diethyl-m-toluamide (DEET) is the repellent most commonly used against mosquito vectors of diseases such as dengue, yellow fever and chikungunya. In Brazil, DEET is marketed in aerosol, solution, lotion and gel forms, at concentrations ranging from 6.65 to 25%. In this study, the kinetic degradation under UVC radiation was studied, as well as the penetration/permeation and the ocular irritant potential of DEET repellents in the form of solution, lotion and gel. The photostability study was conducted over 96h, and the DEET degradation kinetics under UVC radiation was fitted to the zero-order model for the three formulations; t90% values of 23.7 h, 17.0 h and 16.1 h were obtained for gel, lotion and solution forms, respectively. The in vitro skin penetration/permeation using the vertical Franz cell in pig skin showed that all the formulations penetrated/permeated the skin layers, at a higher rate when the lotion (p<0.05) was used, possibly due to its qualitative composition. The in vitro ocular irritant potential using the HET-CAM method indicated that one of the products evaluated was classified as "moderate irritant" and five as "severe irritant”. The set of data indicated the lower penetration/permeation of the solution form and reinforces the importance of being careful during application, to avoid accidental contact with the eyes.
Downloads
References
Moulin E, Selby K, Cherpillod P, Kaiser L, BoillatBlanco N. Simultaneous outbreaks of dengue, chikungunya and Zika virus infections: diagnosis challenge in a returning traveller with nonspecific febrile illness. New Microbes New Infect. 2016; 11:6- 7. doi: 10.1016/j.nmni.2016.02.003.
Secretaria de Vigilância em Saúde. Ministério da Saúde. Boletim Epidemiológico. 2022;53(16):1-14. https://www.gov.br/saude/pt-br/centrais-deconteudo/publicacoes/boletins/boletinsepidemiologicos/edicoes/2022/boletimepidemiologico-vol-53-no16/view.
Croda J. Dengue em 2022: introdução recente na região Sul. Medscape. 2022 May 3. https://portugues.medscape.com/verartigo/6507873
Biernath A. O que está por trás de nova epidemia de dengue no Brasil. BBC News Brasil. 2022 May 02. https://www.bbc.com/portuguese/brasil-61099201.
Aikawa NE, Balbi VA, Borba EF, Tonacio AC, Sallum AME, Campos LMA et al. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine X 2022; 10, 100131. https://doi.org/10.1016/j.jvacx.2021.100131
Islam J, Zaman K, Duarah S, Raju PS, Chattopadhyay P. Mosquito repellents: An insight into the chronological perspectives and novel discoveries. Acta Trop. 2017;167(2):216-30. http://dx.doi.org/10.1016/j.actatropica.2016.12.031.
dos Santos J, Lourenço RL, Rosa P, Adams AIH. Development and validation of a simple HPLC-UV method to assay DEET repellents and its application to different commercial forms. Current Pharm Anal. 2021;17:1051-59. doi:10.2174/1573412916999200703133456.
Tursilli R, Piel G, Delattre L, Scalia S. Solid lipid microparticles containing the sunscreen agent, octyldimethylaminobenzoate: Effect of the vehicle. Eur J Pharm Biopharm. 2007;66(3):483-87. https://doi.org/10.1016/j.ejpb.2007.02.017.
Paese K, Jäger A, Poletto FS, Pinto EF, RossiBergmann B, Pohlmann AR et al. Semisolid formulation containing a nanoencapsulated sunscreen: effectiveness, in vitro photostability and immune response. J Biomed Nanotechnol. 2009;5(3):240-6. doi: 10.1166/jbn.2009.1028.
Silva KER, Alves LDS, Soares MFR, Passos RCS, Faria AR, Rolim Neto PJ. Modelos de avaliação da estabilidade de fármacos e medicamentos para a indústria farmacêutica. Rev Ciênc Farm Básica Apl. 2009;30(2):129–35.
Tsakovska I, Pajeva I, Al Sharif M, Alov P, Fioravanzo E, Kovarich S et al. Quantitative structure-skin permeability relationships. Toxicology. 2017; 387:27-42. doi: 10.1016/j.tox.2017.06.008.
Abdel-Rahman A, Shetty AK, Abou-Donia MB. Subchronic dermal application of N,N-diethyl mtoluamide (DEET) and permethrin to adult rats, alone or in combination, causes diffuse neuronal cell death and cytoskeletal abnormalities in the cerebral cortex and the hippocampus, and Purkinje neuron loss in the cerebellum. Exp Neurol. 2001; 172(1):153–71. doi: 10.1006/exnr.2001.7807.
Stinecipher J, Shah J. Percutaneous permeation of N, N-diethyl-m-toluamide (DEET) from commercial mosquito repellents and the effect of solvent. J Toxicol Env Health. 1997;52(2):119–35. doi: 10.1080/00984109708984056.
Kasichayanula S, House JD, Wang T, Gu X. Simultaneous analysis of insect repellent DEET, sunscreen oxybenzone and five relevant metabolites by reversed-phase HPLC with UV detection: application to an in vivo study in a piglet model. J Chromatogr. B Analyt. Technol Biomed Life Sci. 2005; 822(1-2):271-7. doi: 10.1016/j.jchromb.2005.06.015.
Wang T, Gu X. In vitro percutaneous permeation of the repellent DEET and the sunscreen oxybenzone across human skin. J Pharm Pharmaceut Sci. 2007;10(1):17–25.
MacRae SM, Brown BA, Ubels JL, Edelhauser HF, Dickerson CL. Ocular Toxicity of Diethyltoluamide (Deet). J Toxicol – Cutan Ocul. 1984;3(1):17-30. doi:10.3109/15569528409036270.
Lachman L, De Luca P, Akers A. Testes de estabilidade e fundamentos de cinética química. In: Teoria e Prática na Indústria Farmacêutica. 2nd ed. Lisboa: Fundação Lacouste Gulbenkian; 2001. p. 1277–355.
Nagelreiter C, Raffeiner S, Geyerhofer C, et al. Influence of drug content, type of semi-solid vehicle and rheological properties on the skin penetration of the model drug fluticasone acetate. Influence of drug content, type of semi-solid vehicle and rheological properties on the skin penetration of the model drug fluticasone acetate. Int J Pharm. 2013; 448:305-12.
INVITTOX. 1992. Protocol No. 47: HET-CAM Test. Available from: http://ecvamsis.jrc.it/invittox/published/indexed_47.html.
Moore, D. E. (2004) ‘Photophysical and Photochemical Aspects of Drug Stability’, in TØnessen HH.Photostability of Drugs and Drug Formulations. 2nd edn. Boca Raton: CRC Press LLC, pp. 10–40. doi: 10.1007/s00267-008-9078-6.
International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceutical for Human Use. Stability testing: Photostability testing of new drug substances and products. Q1b. Geneva; 1996.
Tønnesen HH. Photostability testing of drugs and drug formulations - why and how? In: Tønnesen HH, editor. Photostability of drugs and drug formulations. 2nd ed. Boca Raton: CRC Press LLC; 2004.
Tønnesen HH. Formulation and stability testing of photolabile drugs. Int J Pharm. 2001;225(1–2):1-14. https://doi.org/10.1016/S0378-5173(01)00746-3.
Kaushik D, Costache A, Michniak-Kohn B. Percutaneous penetration modifiers and formulation effects. Int J Pharm. 2010;386(1–2):42–51. doi: 10.1016/j.ijpharm.2009.10.052
Karr JI, Speaker TJ, Kasting GB. A novel encapsulation of N,N-diethyl-3-methylbenzamide (DEET) favorably modifies skin absorption while maintaining effective evaporation rates. J Control Release. 2012;160(3):502–8. doi: 10.1016/j.jconrel.2012.04.023.
Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1-2):12-21. doi: 10.1016/j.ijpharm.2013.02.040.
Qiu H, Mccall JW, Jun HW. Formulation of topical insect repellent N,N-diethyl-m-toluamide (DEET): vehicle effects on DEET in vitro skin permeation. Int J Pharm 1998; 63:167–76.
Kasichayanula S, House JD, Tao W, Gu X. Percutaneous characterization of the insect repellent DEET and the sunscreen oxybenzone from topical skin application. Toxicol Appl Pharmacol. 2007; 223:187-94. doi:10.1016/j.taap.2007.05.016.
Wang T, Miller D, Burczynski F, Gu X. Evaluation of percutaneous permeation of repellent DEET and sunscreen oxybenzone from emulsion-based formulations in artificial membrane and human skin. Acta Pharm Sinica B. 2014;4(1):43-51. https://doi.org/10.1016/j.apsb.2013.11.002.
Downloads
Published
Versions
- 25-03-2026 (2)
- 28-07-2022 (1)
How to Cite
Issue
Section
License
Copyright (c) 2022 Drug Analytical Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.





